Search - tctmd.com

Displaying 621 - 640 of 868

Sort: Relevancy | Date

News Conference News TCT 2014

Keynote Address Focuses on Newer DES, Problematic Subgroups

September 15, 2014

News Conference News TCT 2014

EES Decrease Restenosis, TVR vs. BMS in Non-STEMI

September 15, 2014

News Conference News TCT 2014

COMBO Stent Achieves Neointimal Regression at 24 Months

September 15, 2014

Presentation TCT 2014

TCT 643: Very Late Stent Thrombosis After Revascularization with the Biolimus-Eluting, Biodegradable Polymer-Coated Nobori Stent Versus Durable Polymer-Coated, Sirolimus-Eluting Stents from the SORT-OUT V Trial

Presenter: Evald H. Christiansen

September 14, 2014

Presentation TCT 2014

TCT 641: Improved Safety and Reduction in Stent Thrombosis After Everolimus-Eluting Stents Versus Sirolimus-Eluting Stents in Patients with Coronary Artery Disease: SORT-OUT IV 5-Year Results

Presenter: Donald Cutlip, Manel Sabate, Elvin Kedhi, Lisette Okkels Jensen

September 14, 2014

Presentation TCT 2014

Focal Treatment of Vulnerable Plaque: Stents, Scaffolds, and Prospect ABSORB

Presenter: Valentin Fuster, Patrick W. Serruys, Gregg W. Stone

September 14, 2014

Presentation TCT 2014

Case #4: My Preferred Technique When 2 Stents are Needed DK Crush

Presenter: Jean Fajadet, Marie-Claude Morice, Seung-Jung Park, Corrado Tamburino, Shao Liang Chen

September 14, 2014

Presentation TCT 2014

Case #3: My Preferred Technique When 2 Stents are Needed - Culotte

Presenter: Jean Fajadet, Marie-Claude Morice, Seung-Jung Park, Corrado Tamburino

September 14, 2014

Presentation TCT 2014

Case #2: My Preferred Technique When 2 Stents are Needed - T or TAP

Presenter: Jean Fajadet, Marie-Claude Morice, Seung-Jung Park, Corrado Tamburino

September 14, 2014

Presentation TCT 2014

RIBS IV: A Prospective, Randomized Trial of Paclitaxel-Eluting Balloons Versus Everolimus-Eluting Stents in Patients with Coronary In-Stent Restenosis of Drug-Eluting Stents

Presenter: Gregg W. Stone, Pieter C. Smits, Fernando Alfonso

September 14, 2014

News Conference News TCT 2014

RIBS IV: EES Superior to DEB in Patients with In-Stent Restenosis

September 14, 2014

News Conference News TCT 2014

Pooled Trial Data Show No Stent Thrombosis Reduction with Biodegradable Stent

September 14, 2014

News Conference News TCT 2014

PERFECT-LUTS: Endovascular Revascularization Shows Promise for Patients with ED, Lower Urinary Tract Symptoms

Yael L. Maxwell

September 14, 2014

News Conference News TCT 2014

OCT STEMI: Imaging-Guided PCI Shows Promise

September 14, 2014

News Conference News TCT 2014

CTO-IVUS Trial Supports IVUS Guidance for CTO PCI

September 14, 2014

News Conference News TCT 2014

COMPARE II: STEMI Patients See Strong Results with Both BES and EES

September 14, 2014

News Conference News TCT 2014

ABSORB II: Similar Clinical Outcomes, Less Angina with Bioresorbable Scaffold vs. EES

Yael L. Maxwell

September 14, 2014

Presentation TCT 2014

Multilayer Stents for the Treatment of Visceral Aneurysms: Hope or Hoax?

Presenter: John R. Laird Jr, Daniel J. McCormick, Dmitriy N. Feldman, Michel Camille Henry

September 13, 2014

Presentation TCT 2014

Covered Stents for Iliac and SFA Obstructive Disease: Overhyped or Underused?

Presenter: Robert M. Bersin, Dierk Scheinert, Roger Gammon

September 13, 2014

Presentation TCT 2014

Next-Generation Carotid Artery Stents: Are Mesh/Membrane Stents Game Changers?

Presenter: Leo Nelson Hopkins, Sriram S. Iyer, Zvonimir Krajcer, Peter A. Schneider

September 13, 2014

Advertisement

Keynote Address Focuses on Newer DES, Problematic Subgroups

EES Decrease Restenosis, TVR vs. BMS in Non-STEMI

COMBO Stent Achieves Neointimal Regression at 24 Months

TCT 643: Very Late Stent Thrombosis After Revascularization with the Biolimus-Eluting, Biodegradable Polymer-Coated Nobori Stent Versus Durable Polymer-Coated, Sirolimus-Eluting Stents from the SORT-OUT V Trial

TCT 641: Improved Safety and Reduction in Stent Thrombosis After Everolimus-Eluting Stents Versus Sirolimus-Eluting Stents in Patients with Coronary Artery Disease: SORT-OUT IV 5-Year Results

Focal Treatment of Vulnerable Plaque: Stents, Scaffolds, and Prospect ABSORB

Case #4: My Preferred Technique When 2 Stents are Needed DK Crush

Case #3: My Preferred Technique When 2 Stents are Needed - Culotte

Case #2: My Preferred Technique When 2 Stents are Needed - T or TAP

RIBS IV: A Prospective, Randomized Trial of Paclitaxel-Eluting Balloons Versus Everolimus-Eluting Stents in Patients with Coronary In-Stent Restenosis of Drug-Eluting Stents

RIBS IV: EES Superior to DEB in Patients with In-Stent Restenosis

Pooled Trial Data Show No Stent Thrombosis Reduction with Biodegradable Stent

PERFECT-LUTS: Endovascular Revascularization Shows Promise for Patients with ED, Lower Urinary Tract Symptoms

OCT STEMI: Imaging-Guided PCI Shows Promise

CTO-IVUS Trial Supports IVUS Guidance for CTO PCI

COMPARE II: STEMI Patients See Strong Results with Both BES and EES

ABSORB II: Similar Clinical Outcomes, Less Angina with Bioresorbable Scaffold vs. EES

Multilayer Stents for the Treatment of Visceral Aneurysms: Hope or Hoax?

Covered Stents for Iliac and SFA Obstructive Disease: Overhyped or Underused?

Next-Generation Carotid Artery Stents: Are Mesh/Membrane Stents Game Changers?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content